BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)
|
|
|
1 Months Ended |
12 Months Ended |
|
Jul. 03, 2017 |
Jul. 13, 2016 |
Apr. 30, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Jun. 23, 2017 |
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues |
|
202,500
|
11,600
|
|
|
|
| Shares Issued, Price Per Share |
|
$ 45.00
|
$ 11.50
|
|
|
|
| Warrants Issued During Period Value |
|
$ 202,500
|
|
|
|
|
| Warrants Issued Price Per Share |
|
$ 0.10
|
|
|
|
|
| Allowance for Doubtful Accounts Receivable |
|
|
|
$ 271,000
|
$ 253,000
|
|
| Shipping, Handling and Transportation Costs |
|
|
|
87,000
|
137,000
|
|
| Extended Product Warranty Accrual, Current |
|
|
|
$ 40,000
|
$ 118,000
|
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
|
|
|
154,416
|
415,991
|
|
| Stockholders' Equity, Reverse Stock Split |
|
|
|
Reverse Stock Split: Immediately preceding the Merger, Monster Digital shares of common stock were subject to a one-for ten reverse stock split. All share and per share information in these consolidated financial statements, except for par value and authorized shares, have been amended to reflect the reverse stock split.
|
|
|
| Reserve for Sales Returns |
|
|
|
$ 40,000
|
|
|
| Innovates Business [Member] |
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
| Business Acquisition, Transaction Costs |
$ 6,000,000
|
|
|
|
|
|
| Innovate Biopharmaceuticals, Inc. [Member] |
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
| Business Acquisition, Pro Forma Information, Description |
As a result, current stockholders of the Company collectively own approximately 9% and Innovate stockholders collectively own approximately 91% of the combined company on a pro-forma basis, subject to adjustment based on the Companys net cash balance and the relative capitalization of the two companies at closing, as described more fully in the Merger Agreement.
|
|
|
|
|
|
| Business Acquisition, Transaction Costs |
$ 60,000,000
|
|
|
|
|
|
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |
|
|
|
$ 1,000,000
|
|
|
| Offering Common Stock [Member] |
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
|
|
|
99,916
|
202,500
|
|
| Preferred Stock and Bridge Loan [Member] |
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
|
|
|
50,500
|
140,501
|
|
| Other Warrants [Member] |
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
|
|
|
4,000
|
72,990
|
|
| Convertible Notes Payable [Member] |
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
|
|
|
1,384,500
|
38,000
|
|
| Proceeds From The Issuances Initial Public Offering |
|
$ 9,132,750
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
| Shares Issued, Price Per Share |
|
|
|
|
|
$ 5.80
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
|
|
|
1,683
|
10,108
|
|